FindTrial
Sign In

Prospective cohort study on the evaluation of diagnostic efficacy and clinical outcomes of sarcopenia in patients with severe neurological diseases

Epidemiological analysis, multi-method diagnostic efficacy evaluation, and intervention strategy research for sarcopenia in patients with severe neurological diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113549
Enrollment
Unknown
Registered
2025-12-01
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

Sarcopenia group:None
Non-sarcopenia group:None

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with stroke, traumatic brain injury, brain tumor, central nervous system infection, autoimmune encephalitis, status epilepticus, severe neuromuscular disease, etc. admitted to the NICU; 2.GCS= 7 days; 4.Age >=18 years old; 5.Informed consent from the patient or their family members;

Exclusion criteria

Exclusion criteria: 1.Medical record data missing>30%;

Design outcomes

Primary

MeasureTime frame
Mechanical ventilation duration;—

Secondary

MeasureTime frame
ICU length of stay;New fragility fracture;New fall;Total length of hospital stay;Readmission rate within one year;—

Countries

China

Contacts

Public ContactLiu Zhuyun

Guangdong Provincial Hospital of Chinese Medicine

lzhuyunsysu@163.com+86 18825145263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026